National Medical Care Company (TADAWUL:4005)
Saudi Arabia
· Delayed Price · Currency is SAR 164.00
+6.00 (3.80%)
Jun 4, 2025, 3:16 PM AST
TADAWUL:4005 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 1,380 | 1,294 | 1,082 | 917.93 | 845.38 | 808.95 | Upgrade
|
| Revenue Growth (YoY) | 23.37% | 19.59% | 17.85% | 8.58% | 4.50% | 14.19% | Upgrade
|
| Cost of Revenue | 899.08 | 845.11 | 714.93 | 630.99 | 601.08 | 587.78 | Upgrade
|
| Gross Profit | 481.36 | 448.58 | 366.85 | 286.95 | 244.3 | 221.17 | Upgrade
|
| Selling, General & Admin | 185.09 | 167.64 | 124.53 | 93.08 | 79.09 | 107.06 | Upgrade
|
| Other Operating Expenses | -5.69 | -6.33 | -4.03 | -8.35 | -8.19 | - | Upgrade
|
| Operating Expenses | 201.96 | 194.03 | 120.13 | 89.68 | 79.9 | 107.06 | Upgrade
|
| Operating Income | 279.4 | 254.55 | 246.72 | 197.27 | 164.4 | 114.11 | Upgrade
|
| Interest Expense | -25.49 | -22.74 | -3.5 | - | - | - | Upgrade
|
| Interest & Investment Income | 18.03 | 19.48 | 21.37 | 1.24 | - | 0.21 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | - | 8.97 | Upgrade
|
| EBT Excluding Unusual Items | 271.94 | 251.29 | 264.59 | 198.5 | 164.4 | 123.3 | Upgrade
|
| Legal Settlements | 42.34 | 42.34 | - | - | - | - | Upgrade
|
| Pretax Income | 314.28 | 293.63 | 264.59 | 198.5 | 164.4 | 123.3 | Upgrade
|
| Income Tax Expense | 12.04 | -4.54 | 23.67 | 28.43 | 28.04 | 26.03 | Upgrade
|
| Net Income | 302.24 | 298.16 | 240.93 | 170.07 | 136.36 | 97.27 | Upgrade
|
| Net Income to Common | 302.24 | 298.16 | 240.93 | 170.07 | 136.36 | 97.27 | Upgrade
|
| Net Income Growth | 13.65% | 23.76% | 41.66% | 24.73% | 40.18% | 21.45% | Upgrade
|
| Shares Outstanding (Basic) | 45 | 45 | 45 | 45 | 45 | 45 | Upgrade
|
| Shares Outstanding (Diluted) | 45 | 45 | 45 | 45 | 45 | 45 | Upgrade
|
| Shares Change (YoY) | -0.27% | -0.18% | - | - | - | - | Upgrade
|
| EPS (Basic) | 6.76 | 6.66 | 5.37 | 3.79 | 3.04 | 2.17 | Upgrade
|
| EPS (Diluted) | 6.76 | 6.66 | 5.37 | 3.79 | 3.04 | 2.17 | Upgrade
|
| EPS Growth | 13.96% | 23.98% | 41.66% | 24.73% | 40.18% | 21.45% | Upgrade
|
| Free Cash Flow | 393.39 | 136.63 | 412.73 | 185.83 | 61.61 | 93.18 | Upgrade
|
| Free Cash Flow Per Share | 8.79 | 3.05 | 9.20 | 4.14 | 1.37 | 2.08 | Upgrade
|
| Dividend Per Share | 2.000 | 2.000 | 2.000 | 1.000 | 1.000 | 1.000 | Upgrade
|
| Dividend Growth | - | - | 100.00% | - | - | -50.00% | Upgrade
|
| Gross Margin | 34.87% | 34.67% | 33.91% | 31.26% | 28.90% | 27.34% | Upgrade
|
| Operating Margin | 20.24% | 19.68% | 22.81% | 21.49% | 19.45% | 14.11% | Upgrade
|
| Profit Margin | 21.89% | 23.05% | 22.27% | 18.53% | 16.13% | 12.02% | Upgrade
|
| Free Cash Flow Margin | 28.50% | 10.56% | 38.15% | 20.24% | 7.29% | 11.52% | Upgrade
|
| EBITDA | 345.86 | 315.14 | 290.94 | 239.17 | 214.56 | 170.31 | Upgrade
|
| EBITDA Margin | 25.05% | 24.36% | 26.90% | 26.05% | 25.38% | 21.05% | Upgrade
|
| D&A For EBITDA | 66.46 | 60.6 | 44.22 | 41.9 | 50.16 | 56.2 | Upgrade
|
| EBIT | 279.4 | 254.55 | 246.72 | 197.27 | 164.4 | 114.11 | Upgrade
|
| EBIT Margin | 20.24% | 19.68% | 22.81% | 21.49% | 19.45% | 14.11% | Upgrade
|
| Effective Tax Rate | 3.83% | - | 8.95% | 14.32% | 17.06% | 21.11% | Upgrade
|
| Advertising Expenses | - | - | - | - | - | 0.99 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.